Annual FCF
-$118.12 M
-$3.46 M-3.02%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual free cash flow is -$118.12 million, with the most recent change of -$3.46 million (-3.02%) on December 31, 2023.
- During the last 3 years, MRNS annual FCF has fallen by -$57.21 million (-93.92%).
- MRNS annual FCF is now -9472.90% below its all-time high of -$1.23 million, reached on December 31, 2012.
Performance
MRNS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$20.57 M
+$10.31 M+33.39%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly free cash flow is -$20.57 million, with the most recent change of +$10.31 million (+33.39%) on September 30, 2024.
- Over the past year, MRNS quarterly FCF has stayed the same.
- MRNS quarterly FCF is now -553.92% below its all-time high of $4.53 million, reached on September 30, 2021.
Performance
MRNS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$115.93 M
+$4.69 M+3.89%
September 30, 2024
Summary
- As of February 8, 2025, MRNS TTM free cash flow is -$115.93 million, with the most recent change of +$4.69 million (+3.89%) on September 30, 2024.
- Over the past year, MRNS TTM FCF has stayed the same.
- MRNS TTM FCF is now -16391.18% below its all-time high of -$703.00 thousand, reached on March 31, 2013.
Performance
MRNS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MRNS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.0% | 0.0% | 0.0% |
| 3 y3 years | -93.9% | +6.5% | -1.1% |
| 5 y5 years | -323.0% | +6.5% | -1.1% |
MRNS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.4% | at low | at high | +50.4% | -98.6% | +9.7% |
| 5 y | 5-year | -141.0% | at low | -553.9% | +50.4% | -136.5% | +9.7% |
| alltime | all time | -9472.9% | at low | -553.9% | +50.4% | <-9999.0% | +9.7% |
Marinus Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.57 M(-33.4%) | -$115.93 M(-3.9%) |
| Jun 2024 | - | -$30.88 M(-17.6%) | -$120.62 M(+5.7%) |
| Mar 2024 | - | -$37.46 M(+38.6%) | -$114.10 M(-3.4%) |
| Dec 2023 | -$118.12 M(+3.0%) | -$27.03 M(+7.0%) | -$118.12 M(+4.4%) |
| Sep 2023 | - | -$25.26 M(+3.7%) | -$113.10 M(-4.8%) |
| Jun 2023 | - | -$24.36 M(-41.3%) | -$118.75 M(-7.5%) |
| Mar 2023 | - | -$41.48 M(+88.5%) | -$128.40 M(+12.0%) |
| Dec 2022 | -$114.66 M(+96.4%) | -$22.01 M(-28.8%) | -$114.66 M(-0.4%) |
| Sep 2022 | - | -$30.91 M(-9.1%) | -$115.13 M(+44.5%) |
| Jun 2022 | - | -$34.01 M(+22.6%) | -$79.69 M(+14.7%) |
| Mar 2022 | - | -$27.74 M(+23.5%) | -$69.50 M(+19.1%) |
| Dec 2021 | -$58.37 M(-4.2%) | -$22.47 M(-595.9%) | -$58.37 M(+11.6%) |
| Sep 2021 | - | $4.53 M(-119.0%) | -$52.29 M(-26.7%) |
| Jun 2021 | - | -$23.82 M(+43.4%) | -$71.29 M(+12.3%) |
| Mar 2021 | - | -$16.61 M(+1.3%) | -$63.48 M(+4.2%) |
| Dec 2020 | -$60.91 M(+24.3%) | -$16.40 M(+13.3%) | -$60.91 M(+0.2%) |
| Sep 2020 | - | -$14.47 M(-9.6%) | -$60.79 M(+4.2%) |
| Jun 2020 | - | -$16.01 M(+14.0%) | -$58.34 M(+13.8%) |
| Mar 2020 | - | -$14.04 M(-13.8%) | -$51.26 M(+4.6%) |
| Dec 2019 | -$49.02 M(+75.5%) | -$16.28 M(+35.5%) | -$49.02 M(+16.8%) |
| Sep 2019 | - | -$12.02 M(+34.6%) | -$41.98 M(+14.2%) |
| Jun 2019 | - | -$8.93 M(-24.3%) | -$36.77 M(+9.5%) |
| Mar 2019 | - | -$11.80 M(+27.7%) | -$33.56 M(+20.2%) |
| Dec 2018 | -$27.93 M | -$9.23 M(+35.7%) | -$27.93 M(+19.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$6.80 M(+18.8%) | -$23.43 M(+18.4%) |
| Jun 2018 | - | -$5.73 M(-7.0%) | -$19.80 M(+7.3%) |
| Mar 2018 | - | -$6.16 M(+29.9%) | -$18.45 M(-4.2%) |
| Dec 2017 | -$19.27 M(-24.2%) | -$4.74 M(+49.4%) | -$19.27 M(-6.4%) |
| Sep 2017 | - | -$3.17 M(-27.6%) | -$20.58 M(-14.6%) |
| Jun 2017 | - | -$4.38 M(-37.2%) | -$24.10 M(-8.2%) |
| Mar 2017 | - | -$6.97 M(+15.3%) | -$26.25 M(+3.3%) |
| Dec 2016 | -$25.41 M(+24.1%) | -$6.05 M(-9.7%) | -$25.41 M(+4.1%) |
| Sep 2016 | - | -$6.70 M(+2.5%) | -$24.41 M(+3.4%) |
| Jun 2016 | - | -$6.53 M(+6.5%) | -$23.62 M(+4.2%) |
| Mar 2016 | - | -$6.13 M(+21.5%) | -$22.66 M(+10.7%) |
| Dec 2015 | -$20.48 M(+137.5%) | -$5.05 M(-14.5%) | -$20.48 M(+17.7%) |
| Sep 2015 | - | -$5.90 M(+5.8%) | -$17.40 M(+19.1%) |
| Jun 2015 | - | -$5.58 M(+41.1%) | -$14.61 M(+27.9%) |
| Mar 2015 | - | -$3.95 M(+100.8%) | -$11.42 M(+32.9%) |
| Dec 2014 | -$8.62 M(+29.8%) | -$1.97 M(-36.7%) | -$8.59 M(-11.9%) |
| Sep 2014 | - | -$3.11 M(+30.1%) | -$9.75 M(+24.3%) |
| Jun 2014 | - | -$2.39 M(+112.4%) | -$7.85 M(+11.0%) |
| Mar 2014 | - | -$1.13 M(-64.1%) | -$7.07 M(+6.4%) |
| Dec 2013 | -$6.64 M(+438.5%) | -$3.13 M(+160.1%) | -$6.65 M(+89.0%) |
| Sep 2013 | - | -$1.20 M(-25.2%) | -$3.52 M(+52.0%) |
| Jun 2013 | - | -$1.61 M(+128.9%) | -$2.31 M(+228.9%) |
| Mar 2013 | - | -$703.00 K | -$703.00 K |
| Dec 2012 | -$1.23 M | - | - |
FAQ
- What is Marinus Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual FCF year-on-year change?
- What is Marinus Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly FCF year-on-year change?
- What is Marinus Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals TTM FCF year-on-year change?
What is Marinus Pharmaceuticals annual free cash flow?
The current annual FCF of MRNS is -$118.12 M
What is the all time high annual FCF for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual free cash flow is -$1.23 M
What is Marinus Pharmaceuticals annual FCF year-on-year change?
Over the past year, MRNS annual free cash flow has changed by -$3.46 M (-3.02%)
What is Marinus Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of MRNS is -$20.57 M
What is the all time high quarterly FCF for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly free cash flow is $4.53 M
What is Marinus Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, MRNS quarterly free cash flow has changed by $0.00 (0.00%)
What is Marinus Pharmaceuticals TTM free cash flow?
The current TTM FCF of MRNS is -$115.93 M
What is the all time high TTM FCF for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high TTM free cash flow is -$703.00 K
What is Marinus Pharmaceuticals TTM FCF year-on-year change?
Over the past year, MRNS TTM free cash flow has changed by $0.00 (0.00%)